Skip to content
Biodatica
Start free

Investigator

Anand T.n. Kumar

MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NIBIB, NIDCR, NCI

Companies
4

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.1M

Summed across those awards.

First award
Apr 1, 2021

Latest Jan 15, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries

    $638k

    Jan 15, 2025NIBIBMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11101953 (opens the source filing in a new tab)

  2. R01

    Fluorescence lifetime-based intraoperative imaging system for sarcoma surgeries

    $600k

    Jan 15, 2025NIBIBMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11258565 (opens the source filing in a new tab)

  3. R01

    Fluorescence lifetime-based tumor contrast enhancement using exogenous probes

    $451k

    Sep 1, 2024NIDCRMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11195591 (opens the source filing in a new tab)

  4. R01

    Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy

    $457k

    Apr 1, 2021NCIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11114011 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources